Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A S Dzharullaeva

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Acta Naturae|November 7, 2017
Virus-Vectored Ebola VaccinesI V Dolzhikova, E A Tokarskaya, A S Dzharullaeva, et al.
Acta Naturae|April 27, 2019
Immunogenicity of Different Forms of Middle East Respiratory Syndrome S GlycoproteinT A Ozharovskaia, O V Zubkova, I V Dolzhikova, et al.
Acta Naturae|April 23, 2025
The Parameters of Long-Term Humoral Immunity Induced by a Single Injection of the Sputnik Light Vaccine Among Noninfected Volunteers and Those Infected with SARS-CoV-2F M Izhaeva, A I Tukhvatulin, A S Dzharullaeva, et al.
Human Vaccines & Immunotherapeutics|February 3, 2017
Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in RussiaI V Dolzhikova, O V Zubkova, A I Tukhvatulin, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Acta Naturae|November 7, 2017
Virus-Vectored Ebola VaccinesI V Dolzhikova, E A Tokarskaya, A S Dzharullaeva, et al.
Acta Naturae|April 27, 2019
Immunogenicity of Different Forms of Middle East Respiratory Syndrome S GlycoproteinT A Ozharovskaia, O V Zubkova, I V Dolzhikova, et al.
Acta Naturae|April 23, 2025
The Parameters of Long-Term Humoral Immunity Induced by a Single Injection of the Sputnik Light Vaccine Among Noninfected Volunteers and Those Infected with SARS-CoV-2F M Izhaeva, A I Tukhvatulin, A S Dzharullaeva, et al.
Human Vaccines & Immunotherapeutics|February 3, 2017
Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in RussiaI V Dolzhikova, O V Zubkova, A I Tukhvatulin, et al.
Pageof 1